Bodycote plc

As of December 31, 2025, Bodycote plc carries a market capitalization of 1.39B, placing it among publicly traded companies globally. Its enterprise value stands at 1.58B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bodycote plc's next confirmed earnings release is scheduled for March 12, 2027.

As of December 31, 2025, Bodycote plc has 172.55M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Bodycote plc maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on September 30, 2026, Bodycote plc's stock has gained approximately 46.67% over the past 52 weeks. The 50-day moving average sits at 10.33, while the 200-day moving average is 8.81.

As of December 31, 2025, Bodycote plc holds 28.90M in cash and equivalents against 218.81M in total debt, resulting in a net debt position of 120.18M. Total book value stands at 734.17M, with working capital of 36.58M providing operational flexibility.

Bodycote plc's most recent stock split took place on December 9, 2008 with a 19:11 split ratio.